By 2008, the manufacturer (Palatin Technologies) halted nasal formulation trials and pivoted to a subcutaneous injection route, which showed fewer cardiovascular side effects
Behavioral and dietary interventions for weight loss are known to improve psychological well-being, including self-esteem, body image, health-related quality of life, and mental health, suggesting weight loss with GLP-1s may have similar beneficial impacts
Despite this evidence, nutritional support is not routinely provided alongside GLP-1 prescriptions
The peptide distributes systemically through the bloodstream, with fat cell targeting determined by receptor distribution rather than injection location
Tumor cell derived exosomal GOT1 suppresses tumor cell ferroptosis to accelerate pancreatic cancer progression by activating Nrf2/HO-1 axis via upregulating CCR2 expression